Absci Corporation Common Stock

ABSINASDAQUSD
5.13 USD
0.07 (1.36%)🟢PRE MARKET (AS OF 07:48 AM EDT)
🟢Market: OPEN
Open?$5.09
High?$5.09
Low?$5.05
Prev. Close?$5.13
Volume?15.6K
Avg. Volume?5.0M
VWAP?$5.06
Rel. Volume?0.00x
Bid / Ask
Bid?$4.36 × 100
Ask?$5.88 × 100
Spread?$1.52
Midpoint?$5.12
Valuation & Ratios
Market Cap?799.8M
Shares Out?155.9M
Float?108.6M
Float %?72.2%
P/E Ratio?N/A
P/B Ratio?4.65
EPS?-$0.76
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Employees
140
Market Cap
799.8M
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2021-07-22
Address
18105 SE MILL PLAIN BLVD
VANCOUVER, WA 98683
Phone: (360) 949-1041
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.59Strong
Quick Ratio?6.59Strong
Cash Ratio?0.43Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
58/100
P/E?
N/A
P/B?
4.65FAIR
P/S?
435.62HIGH
P/FCF?
N/A
EV/EBITDA?
-7.1CHEAP
EV/Sales?
431.14HIGH
Returns & Efficiency
ROE?
-68.9%WEAK
ROA?
-60.6%WEAK
Cash Flow & Enterprise
FCF?$-98505000
Enterprise Value?$791.6M
Fundamentals ratios updated end of day